AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...

AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival ...

AstraZeneca's breast cancer drug datopotamab deruxtecan didn't show a statistical significance in overall survival compared with chemotherapy, results showed at a phase three trial.

Experts have developed a breakthrough small-molecule drug, a 'protein degrader'. This molecule, called ACBI3, could potentially lead to new therapies independent of KRAS mutation type, improving ...

AstraZeneca said on Monday its experimental precision drug developed with Daiichi Sankyo did not significantly improve ...

Pakistan PM Shehbaz to raise Kashmir, Palestine, Islamophobia issues at UNGA Pakistan Prime Minister Shehbaz Sharif is set to address the United Nations General Assembly on September 27. He will ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Ryan Routh, aged 58, allegedly attempted to assassinate former President Donald Trump at his Florida golf course by aiming a rifle through the tree line. He had earlier written a letter offering $ ...

Trump and the Republican National Committee he controls decided to share get-out-the-vote duties in the most competitive states with groups such as the one supported by billionaire Elon Musk.

The iPhone 16 Pro's High-Res Slow Motion Video Is the Best Apple Feature in Years ...

This thesis focuses on identifying prognostic and predictive biomarkers that may guide treatment decisions for patients with early-stage HER2-negative breast cancer (BC) or triple-negative BC (eTNBC).